Adhera Therapeutics Appoints Nancy Phelan as Chief Executive Officer
04 avr. 2019 09h15 HE
|
Adhera Therapeutics, Inc.
RESEARCH TRIANGLE PARK, NC, April 04, 2019 (GLOBE NEWSWIRE) -- Adhera Therapeutics, Inc. (OTCQB: ATRX), a specialty pharmaceutical company leveraging technology to commercialize unique therapies and...
Marina Biotech Appoints Uli Hacksell, Ph.D. and Robert C. Moscato to Board of Directors
29 juin 2018 09h15 HE
|
Marina Biotech, Inc.
City of Industry, CA, June 29, 2018 (GLOBE NEWSWIRE) -- Marina Biotech, Inc. (OTCQB: MRNA), a commercial stage pharmaceutical company focused on the development and commercialization of innovative...